Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer

dc.contributor.authorBonaventura, Jordi
dc.contributor.authorNavarro Brugal, Gemma
dc.contributor.authorCasadó Anguera, Verònica
dc.contributor.authorAzdad, Karima
dc.contributor.authorRea, William
dc.contributor.authorMoreno Guillén, Estefanía
dc.contributor.authorBrugarolas Campillos, Marc
dc.contributor.authorMallol Montero, Josefa
dc.contributor.authorCanela Campos, Enric I. (Enric Isidre), 1949-
dc.contributor.authorLluís i Biset, Carme
dc.contributor.authorCortés Tejedor, Antonio
dc.contributor.authorVolkow, Nora D.
dc.contributor.authorSchiffmann, Serge N.
dc.contributor.authorFerré, Sergi
dc.contributor.authorCasadó, Vicent
dc.date.accessioned2023-02-10T17:52:06Z
dc.date.available2023-02-10T17:52:06Z
dc.date.issued2015-07-07
dc.date.updated2023-02-10T17:52:06Z
dc.description.abstractAdenosine A2A receptor (A2AR)-dopamine D2 receptor (D2R) heteromers are key modulators of striatal neuronal function. It has been suggested that the psychostimulant effects of caffeine depend on its ability to block an allosteric modulation within the A2AR-D2R heteromer, by which adenosine decreases the affinity and intrinsic efficacy of dopamine at the D2R. We describe novel unsuspected allosteric mechanisms within the heteromer by which not only A2AR agonists, but also A2AR antagonists, decrease the affinity and intrinsic efficacy of D2R agonists and the affinity of D2R antagonists. Strikingly, these allosteric modulations disappear on agonist and antagonist coadministration. This can be explained by a model that considers A2AR-D2R heteromers as heterotetramers, constituted by A2AR and D2R homodimers, as demonstrated by experiments with bioluminescence resonance energy transfer and bimolecular fluorescence and bioluminescence complementation. As predicted by the model, high concentrations of A2AR antagonists behaved as A2AR agonists and decreased D2R function in the brain.
dc.format.extent10 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec652885
dc.identifier.issn0027-8424
dc.identifier.pmid26100888
dc.identifier.urihttps://hdl.handle.net/2445/193423
dc.language.isoeng
dc.publisherNational Academy of Sciences
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1073/pnas.1507704112
dc.relation.ispartofProceedings of the National Academy of Sciences of the United States of America - PNAS, 2015, vol. 112, num. 27, p. E3609-E3618
dc.relation.urihttps://doi.org/10.1073/pnas.1507704112
dc.rights(c) Bonaventura, Jordi et al., 2015
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject.classificationAdenosina
dc.subject.classificationDopamina
dc.subject.classificationCafeïna
dc.subject.otherAdenosine
dc.subject.otherDopamine
dc.subject.otherCaffeine
dc.titleAllosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
652885.pdf
Mida:
1.84 MB
Format:
Adobe Portable Document Format